Our signature high-purity extraction series, compliant with international CE and regulatory standards, engineered for immediate deployment in Baku's clinical research labs and pharmaceutical compounding facilities.
The Republic of Azerbaijan, positioned strategically along the Caspian Sea and acting as a central logistics corridor between Europe and Central Asia, is experiencing a major transformation in its domestic pharmaceutical and chemical manufacturing sectors. In alignment with the "Strategic Roadmap for the National Economy of the Republic of Azerbaijan", the government is aggressively promoting the diversification of its non-oil sectors. A key beneficiary of this policy is the domestic healthcare industry.
As Azerbaijan modernizes its clinical frameworks, particularly within key technology hubs like the **Sumgait Chemical Industrial Park (SCIP)** and research clusters in Baku, the demand for premium active pharmaceutical ingredients (APIs), biological standard substances, and extraction products has risen sharply. Bile acids, specifically from the Cholic Acid Series, are crucial components in metabolic therapies, liver disease therapeutics, diagnostic reagents, and modern drug formulation research.
Cholic acid (CA) and its conjugated derivatives (such as TUDCA, GCA, and sodium deoxycholate) are not merely industrial detergents. They serve as essential ligands for the Farnesoid X Receptor (FXR) and the G-protein coupled bile acid receptor 5 (TGR5). These receptors regulate systemic glucose, lipid, and energy metabolism.
For researchers and clinical compounding facilities in Azerbaijan, these compounds are critical for:
A comprehensive look at the chemical profiles of our Cholic Acid derivative portfolio. Designed to ensure full transparency, traceability, and alignment with world-class monographs (USP, EP, BP).
| Product Derivative | CAS Number | Standard Assay (HPLC) | Primary Therapeutic Target | Key Application Field |
|---|---|---|---|---|
| Cholic Acid (CA) | 81-25-4 | ≥ 98.0% | Bile acid synthesis deficiency | API Synthesis, Emulsification |
| Ursodeoxycholic Acid (UDCA) | 128-13-2 | ≥ 99.0% | Cholestatic liver diseases, gallstones | Clinical Drug Formulation |
| Tauroursodeoxycholic Acid (TUDCA) | 14605-22-2 | ≥ 98.5% | Endoplasmic reticulum stress mitigation | Neurodegenerative disease research |
| Chenodeoxycholic Acid (CDCA) | 474-25-9 | ≥ 98.0% | Cerebrotendinous xanthomatosis | Bile acid precursor studies |
| Deoxycholic Acid (DCA) | 83-44-3 | ≥ 98.0% | Adipose tissue reduction | Aesthetic medicine injections |
Understanding pricing structures is essential for optimization. Our analysis details the variables driving market pricing in the South Caucasus region.
Natural extraction of cholic acid depends heavily on global livestock markets (bovine and porcine bile yields). Changes in cattle and pig supply chains directly influence the base cost of raw paste, impacting overall pricing strategies for finished APIs.
Industrial-grade bile acids are significantly cheaper than pharmaceutical-grade equivalents. A higher HPLC purity assay requirement (e.g., >99% UDCA) demands extensive multi-stage recrystallization and column chromatography, raising the final production cost.
Exporting to Azerbaijan requires meeting local Ministry of Health standards (Analitik Ekspertiza Mərkəzi). Completing DMF, CEP, and veterinary health clearance dossiers involves substantial compliance costs that are factored into long-term contract pricing.
Need an official quotation customized for your specific pharmaceutical project in Baku?
Send Inquiry NowEstablished in 2012, Chengdu Chenlv Herb Co., Ltd. ("Chenlv Herb") is a premier high-tech enterprise dedicated to the research, development, manufacturing, and distribution of premium botanical extracts and natural pharmaceutical APIs. We specialize in providing high-purity, bio-active, and certified natural raw materials designed for global pharmaceutical, nutraceutical, veterinary, and cosmetics industries.
By integrating advanced extraction technologies with strict GMP-compliant quality assurance frameworks, we supply foundational components like the Cholic Acid series to clients around the world. We offer comprehensive support, including complete documentation, stability data, and technical consultation to ensure seamless registration and launch in demanding markets like Azerbaijan.
We provide high-purity natural ingredients alongside comprehensive compliance, customization, and logistical support designed to meet modern industrial needs.
Our in-house R&D team continuously refines isolation pathways and enzymatic crystallization methods, allowing us to supply high-purity, difficult-to-synthesize bile conjugates.
Equipped with modern production lines, we ensure rapid processing of raw materials to maintain reliable inventories and meet your urgent manufacturing timelines.
We implement eco-friendly closed-loop recycling processes for extraction solvents and animal source derivatives, promoting sustainability across our entire supply chain.
From initial lab-scale testing to full-scale commercial manufacturing, our technical customer support provides timely updates, clear communication, and support within 24 hours.
Every batch undergoes stringent QC verification. We verify purity, heavy metal content, residual solvents, and microbial limits to deliver dependable products.
With decades of experience in the international biochemical sector, we understand the regulatory and quality requirements of global buyers and local markets.
Cholic acid derivatives find critical applications across human therapeutics, functional foods, dermatological science, and animal wellness.
Driven by modern preventative health trends, plant extracts and bile acid compounds are increasingly integrated into premium dietary supplements, supporting lipid digestion and cellular metabolic health.
Active active ingredients like UDCA are crucial for formulating hepatoprotective drugs. They serve as primary components in therapies designed to dissolve gallstones and treat chronic biliary diseases.
In aesthetic medicine and topical formulations, bile acid derivatives like Deoxycholic Acid are utilized in specialized applications, helping compound modern emulsions and target localized fat deposits.
Bile acid additives are increasingly adopted in veterinary feeds, helping optimize fat emulsification, protect liver function, and improve feed conversion efficiency in livestock.
A step-by-step workflow designed to ensure complete compliance, precise customization, and reliable delivery to your facility in Azerbaijan.
We work to understand your specific assay and purity requirements.
We provide a competitive quote based on your order volume and specs.
We establish clear terms for quality assurance and timelines.
Our lab prepares and delivers validation samples for analysis.
We manufacture batch quantities in our GMP-compliant plant.
Every batch undergoes testing and receives a detailed Certificate of Analysis (COA).
We manage logistics and customs to ensure secure delivery to Azerbaijan.
Our manufacturing operations comply with strict global regulatory standards, meeting quality, safety, and cultural requirements.
Browse our core selection of active bile derivatives and therapeutic solutions, manufactured in compliance with international guidelines.
Our full portfolio includes these specialized research and manufacturing components, complete with technical documentation.
The global chemical industry is transitioning from traditional extraction methods toward hybrid enzymatic systems and sustainable engineering. Historically, cholic acid and its derivative molecules (such as dehydrocholic acid and glycocholic acid) were isolated from bovine or porcine bile collected at slaughterhouses. While animal extraction remains a reliable source, maintaining high purity and viral safety (BSE/TSE clearance) requires advanced purification protocols.
Chengdu Chenlv Herb is at the forefront of this industrial shift. We invest in research exploring cell-free enzymatic bioconversion. This technique uses specific bacterial hydroxylases to convert simple cholic acids into high-value compounds like UDCA and TUDCA.
By implementing sustainable production workflows, we significantly reduce solvent usage while boosting yields. These clean methods are designed to lower trace impurity profiles, helping customers meet increasingly strict pharmaceutical regulatory guidelines worldwide.
Stay informed on market dynamics, pricing fluctuations, and our global exhibition calendar.
Raw material price changes in China continue to shape the botanical extract market. Our update examines supply-demand dynamics and their impact on extraction costs.
We look forward to connecting with global partners at CPHI China 2025 in Shanghai to discuss new trends in botanical extraction and chemical synthesis.
Our team showcased our latest high-purity APIs and plant extraction solutions in Guangzhou, expanding our collaborative network.
Find detailed answers to common inquiries regarding specifications, compliance, and logistics for the Azerbaijan market.
Contact our technical team to request sample validation, request a formal pricelist, or discuss regulatory registration requirements.
Send Inquiry Now